account_balance
Investment manager · 13F filer · SEC CIK 1515070
Tetragon Partners GP Ltd
Reported value$614Mas of Jun 30, 2026
Positions32 5 new, 7 sold out
Top 10 weight76.5%PATH alone is 55%
FiledAug 1344 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PATHUipath Inc
54.8%Added +23%
KGEIKolibri Global Energy Inc
5.5%
AUTL2.5%LYFTLyft Inc
2.4%
DFTX2.2%WK2.0%CXMSprinklr Inc
1.8%
MBXMBX Biosciences Inc
1.8%Added +40%
ALKT1.8%CLDX1.8%RLAY1.7%ARWR1.7%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
PATH Uipath Inc 54.8% Added +23%KGEI Kolibri Global Energy Inc 5.5% HeldAUTL Autolus Therapeutics Ltd 2.5% HeldLYFT Lyft Inc 2.4% HeldDFTX Definium Therapeutics Inc 2.2% Added +43%WK Workiva Inc 2.0% HeldCXM Sprinklr Inc 1.8% HeldMBX MBX Biosciences Inc 1.8% Added +40%ALKT Alkami Technology Inc 1.8% NewCLDX Celldex Therapeutics Inc New 1.8% Trimmed −7%RLAY Relay Therapeutics Inc 1.7% Added +214%ARWR Arrowhead Pharmaceuticals In 1.7% Added +3%
What changed